Related Experiment Video
Updated: Apr 1, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Inflammatory bowel disease in Turkish children
Murat Cakir1, Fatih Unal2,3, Gonul Dinler2,4
1, Trabzon, Turkey. muratcak@hotmail.com.
Inflammatory bowel disease (IBD) in Turkish children shows similar features to other populations, with ulcerative colitis being most common. Further studies are needed to determine the true incidence of pediatric IBD in Turkey.
Area of Science:
- Pediatric Gastroenterology
- Clinical Research
- Epidemiology
Background:
- Inflammatory bowel disease (IBD) is a growing concern in pediatric populations worldwide.
- Understanding the specific demographic and clinical characteristics of IBD in Turkish children is crucial for effective management.
Purpose of the Study:
- To evaluate the demographics, clinical manifestations, laboratory findings, and outcomes of pediatric inflammatory bowel disease (IBD) in Turkey.
- To identify patterns and potential risk factors in a Turkish pediatric IBD cohort.
Main Methods:
- Retrospective analysis of medical records for 127 children diagnosed with IBD (under 18 years) between 2004 and 2012.
- Data collected from 8 pediatric gastroenterology centers across Turkey.
- Inclusion criteria: diagnosis of IBD before age 18.
Main Results:
- Ulcerative colitis (UC) affected 70.9% of patients, Crohn's disease (CD) 22.8%, and IBD unclassified 6.3%.
- The mean age was 11.6 years; males predominated in CD (72.4%) versus UC (42.2%).
- Extra-intestinal manifestations and associated diseases were more frequent in early-onset disease (OR=4.02 and OR=4.1, respectively).
Conclusions:
- Pediatric IBD is an increasing clinical entity in Turkey.
- The clinical features of IBD in Turkish children resemble those reported in international cohorts.
- Prospective multicenter studies are recommended to ascertain the true incidence of IBD in Turkish children.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...